SAN ANTONIO – A Phase II trial of Novartis' CDK4/6 inhibitor Kisqali (ribociclib) plus endocrine therapy showed improvement in progression-free ...
News
- Kisqali Outperforms Combination Chemo in Aggressive HR-Positive, HER2-Negative Breast Cancer
- First-Line CDK4/6 Thumps Chemo in Aggressive, Advanced Breast Cancer
SAN ANTONIO -- A CDK4/6 inhibitor plus endocrine therapy combination ... Pfizer, Seagen, Daiichi Sankyo, Puma Biotechnology, and Novartis.
- Natera to Present New Signatera™ and Empower™ Data at the 2022 Annual San Antonio ...
... Signatera, and its hereditary cancer test, Empower, at the 2022 San Antonio Breast Cancer Symposium (SABCS) in San Antonio, Texas.
- hC Bioscience Appoints Martin Maier, Ph.D. to its Scientific Advisory Board
hC Bioscience Appoints Martin Maier PhD to its Scientific Advisory Board Brings ... Salt Lake City News · San Antonio News · San Diego News ...
- San Antonio man dies in head-on crash on SH-285 | CW39 Houston
CORPUS CHRISTI, Texas (ValleyCentral) — A San Antonio man died Tuesday in a head-on collision on State Highway 285. Nathaniel Lucas Ghidoni, 43, ...